Yuval Shemer

402 total citations
10 papers, 284 citations indexed

About

Yuval Shemer is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yuval Shemer has authored 10 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yuval Shemer's work include Pluripotent Stem Cells Research (5 papers), Cardiomyopathy and Myosin Studies (4 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Yuval Shemer is often cited by papers focused on Pluripotent Stem Cells Research (5 papers), Cardiomyopathy and Myosin Studies (4 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Yuval Shemer collaborates with scholars based in Israel, Romania and Germany. Yuval Shemer's co-authors include Ofer Binah, Ronen Ben Jehuda, Mihaela Gherghiceanu, Lucy N. Mekies, Michael Arad, Irina Reiter, Dov Freimark, Kaomei Guan, Huanhuan Cui and Silke Sperling and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and European Heart Journal.

In The Last Decade

Yuval Shemer

10 papers receiving 283 citations

Peers

Yuval Shemer
Ronen Ben Jehuda Israel
Sureshkumar Perumal Srinivasan Germany
Maryna Panamarova United Kingdom
Julia M. Giger United States
Alexander P. Murphy United Kingdom
Alain Hirschy Switzerland
Irina Reiter Israel
Meikun Kan-o Japan
Stephanie Hirner Germany
Sherin I. Hashem United States
Ronen Ben Jehuda Israel
Yuval Shemer
Citations per year, relative to Yuval Shemer Yuval Shemer (= 1×) peers Ronen Ben Jehuda

Countries citing papers authored by Yuval Shemer

Since Specialization
Citations

This map shows the geographic impact of Yuval Shemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuval Shemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuval Shemer more than expected).

Fields of papers citing papers by Yuval Shemer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuval Shemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuval Shemer. The network helps show where Yuval Shemer may publish in the future.

Co-authorship network of co-authors of Yuval Shemer

This figure shows the co-authorship network connecting the top 25 collaborators of Yuval Shemer. A scholar is included among the top collaborators of Yuval Shemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuval Shemer. Yuval Shemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Shemer, Yuval, Lucy N. Mekies, Ronen Ben Jehuda, et al.. (2021). Investigating LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. International Journal of Molecular Sciences. 22(15). 7874–7874. 10 indexed citations
2.
Shemer, Yuval, et al.. (2020). Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening. International Journal of Molecular Sciences. 21(19). 7320–7320. 21 indexed citations
3.
Jehuda, Ronen Ben, Lucy N. Mekies, Yuval Shemer, et al.. (2019). Electrophysiological abnormalities in induced pluripotent stem cell‐derived cardiomyocytes generated from Duchenne muscular dystrophy patients. Journal of Cellular and Molecular Medicine. 23(3). 2125–2135. 31 indexed citations
4.
Schick, Revital, Lucy N. Mekies, Yuval Shemer, et al.. (2018). Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy. PLoS ONE. 13(10). e0205719–e0205719. 36 indexed citations
5.
Jehuda, Ronen Ben, Yuval Shemer, & Ofer Binah. (2018). Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9. Stem Cell Reviews and Reports. 14(3). 323–336. 102 indexed citations
6.
Jehuda, Ronen Ben, Yuval Shemer, Lucy N. Mekies, et al.. (2018). CRISPR correction of the PRKAG2 gene mutation in the patient's iPSC-derived cardiomyocytes eliminates the electrophysiological and structural abnormalities. 2 indexed citations
7.
Jehuda, Ronen Ben, Yuval Shemer, Lucy N. Mekies, et al.. (2017). CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities. Heart Rhythm. 15(2). 267–276. 49 indexed citations
8.
Jehuda, Ronen Ben, et al.. (2017). A Method Sustaining the Bioelectric, Biophysical, and Bioenergetic Function of Cultured Rabbit Atrial Cells. Frontiers in Physiology. 8. 584–584. 8 indexed citations
9.
Shemer, Yuval, Ronen Ben Jehuda, Lucy N. Mekies, et al.. (2017). Investigating the cardiac pathology of SCO2‐mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell–derived cardiomyocytes. Journal of Cellular and Molecular Medicine. 22(2). 913–925. 23 indexed citations
10.
Schick, Revital, Lucy N. Mekies, Yuval Shemer, et al.. (2017). P3496Functional abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from titin-mutated dilated cardiomyopathy patients. European Heart Journal. 38(suppl_1). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronen Ben Jehuda Breakdown of academic impact, for papers by Sureshkumar Perumal Srinivasan Breakdown of academic impact, for papers by Maryna Panamarova Breakdown of academic impact, for papers by Julia M. Giger Breakdown of academic impact, for papers by Alexander P. Murphy Breakdown of academic impact, for papers by Alain Hirschy Breakdown of academic impact, for papers by Irina Reiter Breakdown of academic impact, for papers by Meikun Kan-o Breakdown of academic impact, for papers by Stephanie Hirner Breakdown of academic impact, for papers by Sherin I. Hashem
Rankless by CCL
2026